Results 91 to 100 of about 328 (177)

Planeta tardo

, 2011
[EN] Definition of the word Planeta tardo in the dictionary Dicter.
openaire   +1 more source

Clinical evidence and implementation guidance for biosimilar switching in ankylosing spondylitis. [PDF]

Front Pharmacol
Cai L, Chen X, Fang Y, Li L, Liu T, Gan Z, Zuo Z.   +6 more
europepmc   +1 more source

Switching from originator biological agents to biosimilars: what is the evidence and what are the issues? [PDF]

RMD Open, 2017
Toussirot E, Marotte H.
europepmc   +1 more source

Evaluation of adverse events focusing on infection associated with infliximab originator and biosimilar using a spontaneous reporting system database. [PDF]

J Pharm Health Care Sci, 2019
Niinomi I, Hosohata K, Mori Y, Yamaguchi Y, Wakabayashi T, Uchida M, Iwanaga K.   +6 more
europepmc   +1 more source

Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis. [PDF]

J Clin Med
Uslu S, Gülle S, Sen G, Capar S, Senel S, Dalkılıc E, Akar S, Koca SS, Tufan A, Yazici A, Yilmaz S, Inanc N, Birlik M, Solmaz D, Cefle A, Goker B, Direskeneli H, Yolbas S, Steen Krogh N, Yilmaz N, Erten S, Bes C, Soysal Gündüz O, Oztürk MA, Haznedaroglu S, Yavuz S, Onen F, Sari I.   +27 more
europepmc   +1 more source

Path of Interchangeability of Biosimilars in Pediatric Inflammatory Bowel Disease: Quality Before Cost Savings. [PDF]

J Pediatr Gastroenterol Nutr, 2017
Patel D, Park KT.
europepmc   +1 more source

The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review. [PDF]

Clin Pharmacol Ther, 2020
Barbier L, Ebbers HC, Declerck P, Simoens S, Vulto AG, Huys I.   +5 more
europepmc   +1 more source

Planeta opreso

, 2011
[ES] Definición del término Planeta opreso en el diccionario Dicter.
openaire   +1 more source

Type 1 interferon signature and allograft inflammatory factor-1 contribute to refractoriness to TNF inhibition in ankylosing spondylitis. [PDF]

Nat Commun
Song W, Lee EE, Park S, Choi B, Kim MG, Ban SY, Choi SR, Kim JY, Kim SU, Kim JI, Shin EC, Jung I, Lee JS, Lee EY, Single-Cell Atlas of Immune Diseases Consortium.   +14 more
europepmc   +1 more source

Retention Rate and Efficacy of the Biosimilar CT-P13 Versus Reference Infliximab in Patients with Ankylosing Spondylitis: A Propensity Score-Matched Analysis from the Korean College of Rheumatology Biologics Registry. [PDF]

BioDrugs, 2020
Kim HA, Lee E, Lee SK, Park YB, Shin K.
europepmc   +1 more source